OPKO Health, Inc. (NASDAQ:OPK) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman & CEO Elias Zerhouni - President & Vice Chairman Steven Rubin - EVP, Administration & Director Gary Nabel - Chief Innovation Officer & Director Adam Logal - SVP, CFO, CAO & Treasurer Conference Call Participants Kevin Strang - Jefferies Jeffrey Cohen - Ladenburg Thalmann Edward Tenthoff - Piper Sandler Yale Jen - Laidlaw & Company Y ...

OPKO Health, Inc. (NASDAQ:OPK) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Officer Adam Logal - SVP and Chief Financial Officer Jon Cohen - SVP and Executive Chairman Elias Zerhouni - President and Vice Chairman Conference Call Participants Kevin Strang - Jefferies Jeffrey S. Cohen - Ladenburg Thalmann Company Inc. Edward Tenthoff - Piper Sandler Operator Good day and welcome to the OPKO ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33528 OPKO Health, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdicti ...

OPKO Health, Inc. (NASDAQ:OPK) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Officer Adam Logal - SVP and Chief Financial Officer Jon Cohen - SVP and Executive Chairman Elias Zerhouni - President and Vice Chairman Conference Call Participants Kevin Strang - Jefferies Operator Good day and welcome to the OPKO Health's Second Quarter 2022 Financial Results Conference Call. All participants wil ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33528 OPKO Health, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of ...

OPKO Health, Inc. (NASDAQ:OPK) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Yvonne Briggs - LHA Phillip Frost - Chairman & CEO Adam Logal - SVP, CFO, CAO & Treasurer Jon Cohen - SVP & Director Elias Zerhouni - Incoming President & Vice Chairman Conference Call Participants Kevin Strang - Jefferies Jeffrey Cohen - Ladenburg Thalmann & Co. Operator Good afternoon, and welcome to OPKO Health's First Quarter 2022 Financial Results Conference Call. All participants are in a listen ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33528 OPKO Health, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction o ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-33528 OPKO Health, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Inc ...

OPKO Health, Inc. (NASDAQ:OPK) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Yvonne Briggs - Investor Relations Phillip Frost - Chairman & Chief Executive Officer Steve Rubin - Executive Vice President Jon Cohen - Managing Director, Executive Chairman of BioReference Laboratories Adam Logal - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Operator Good day, ladies and gentlemen. And welcome to the OPKO Health Inc. Fourth Quarter 2021 Finan ...

OPKO Health Inc. (NASDAQ:OPK) Q3 2021 Financial Results Conference Call October 28, 2021 4:30 PM ET Company Participants Yvonne Briggs – LHA Investor Relations Phillip Frost – Chairman and Chief Executive Officer Steve Rubin – Executive Vice President Jon Cohen – Senior Vice President, BioReference Laboratories Adam Logal – Chief Financial Officer Conference Call Participants Kevin Strang – Jefferies Edward Tenthoff – Piper Sandler Jeffrey Cohen – Ladenburg Yale Jen – Laidlaw & Company Operator Good day, la ...